Guardant Health to Report Third Quarter 2024 Financial Results on November 6, 2024
Guardant Health (Nasdaq: GH), a leading precision oncology company, has announced it will report its third quarter 2024 financial results after market close on Wednesday, November 6, 2024. The company management will host a conference call and webcast at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time on the same day to discuss the results.
Interested parties can access the live audio webcast on the 'Investors' section of the Guardant Health website at www.guardanthealth.com. For those unable to attend the live event, an archived version of the webcast will be available for replay after the call.
Guardant Health (Nasdaq: GH), una delle principali aziende di oncologia di precisione, ha annunciato che riferirà i suoi risultati finanziari del terzo trimestre 2024 dopo la chiusura del mercato il mercoledì 6 novembre 2024. Il management dell'azienda ospiterà una teleconferenza e un webcast alle 17:30 ora del Pacifico / 20:30 ora dell'Est nello stesso giorno per discutere i risultati.
Le parti interessate possono accedere al webcast audio in diretta nella 'sezione Investitori' del sito web di Guardant Health all'indirizzo www.guardanthealth.com. Per coloro che non possono partecipare all'evento dal vivo, sarà disponibile una versione archiviata del webcast per la riproduzione dopo la chiamata.
Guardant Health (Nasdaq: GH), una de las principales empresas de oncología de precisión, ha anunciado que informará sobre sus resultados financieros del tercer trimestre de 2024 después del cierre del mercado el miércoles 6 de noviembre de 2024. La dirección de la empresa llevará a cabo una conferencia telefónica y un webcast a las 13:30 hora del Pacífico / 16:30 hora del Este ese mismo día para discutir los resultados.
Las partes interesadas pueden acceder al webcast de audio en vivo en la 'sección de Inversores' del sitio web de Guardant Health en www.guardanthealth.com. Para aquellos que no puedan asistir al evento en vivo, habrá una versión archivada del webcast disponible para su reproducción después de la llamada.
Guardant Health (Nasdaq: GH)는 정밀 종양학 분야의 선두 기업으로서, 2024년 3분기 재무 결과를 2024년 11월 6일 수요일 시장 마감 후 발표할 것이라고 발표했습니다. 회사 관리자는 같은 날 태평양 표준시 오후 1:30 / 동부 표준시 오후 4:30에 결과를 논의하기 위해 컨퍼런스 콜 및 웨비나를 개최할 것입니다.
관심 있는 분들은 Guardant Health 웹사이트의 '투자자 섹션'에서 실시간 오디오 웨비나에 접속할 수 있습니다 www.guardanthealth.com. 생방송에 참석할 수 없는 분들을 위해, 통화 후 다시 볼 수 있는 웨비나의 아카이브 버전이 제공될 예정입니다.
Guardant Health (Nasdaq: GH), une entreprise leader dans le domaine de l'oncologie de précision, a annoncé qu'elle publiera ses résultats financiers du troisième trimestre 2024 après la fermeture du marché le mercredi 6 novembre 2024. La direction de l'entreprise animera une conférence téléphonique et un webinaire le même jour à 13h30, heure du Pacifique / 16h30, heure de l'Est pour discuter des résultats.
Les parties intéressées peuvent accéder au webinaire audio en direct dans la 'section Investisseurs' du site Web de Guardant Health à l'adresse www.guardanthealth.com. Pour ceux qui ne peuvent pas assister à l'événement en direct, une version archivée du webinaire sera disponible en replay après l'appel.
Guardant Health (Nasdaq: GH), ein führendes Unternehmen im Bereich der präzisen Onkologie, hat bekannt gegeben, dass es seine finanziellen Ergebnisse für das dritte Quartal 2024 nach Handelsende am Mittwoch, dem 6. November 2024 veröffentlichen wird. Das Management des Unternehmens wird am selben Tag um 13:30 Uhr Pazifischer Zeit / 16:30 Uhr Eastern Time eine Telefonkonferenz und einen Webcast abhalten, um die Ergebnisse zu diskutieren.
Interessierte Parteien können den Live-Audio-Webcast im 'Investorenbereich' der Website von Guardant Health unter www.guardanthealth.com abrufen. Für diejenigen, die an der Live-Veranstaltung nicht teilnehmen können, wird eine archivierte Version des Webcasts nach dem Anruf zur Verfügung stehen.
- None.
- None.
Live audio of the webcast will be available on the “Investors” section of the company website at: www.guardanthealth.com. The webcast will be archived and available for replay after the event.
About Guardant Health
Guardant Health is a leading precision oncology company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, Guardant is transforming patient care and accelerating new cancer therapies by providing critical insights into what drives disease through its advanced blood and tissue tests, real-world data and AI analytics. Guardant tests help improve outcomes across all stages of care, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and treatment selection for patients with advanced cancer. For more information, visit guardanthealth.com and follow the company on LinkedIn, X (Twitter) and Facebook.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241015612501/en/
Investor Contact:
Zarak Khurshid
investors@guardanthealth.com
Media Contact:
Melissa Marasco
press@guardanthealth.com
+1 650-647-3711
Source: Guardant Health, Inc.
FAQ
When will Guardant Health (GH) report its Q3 2024 financial results?
What time is Guardant Health's (GH) Q3 2024 earnings call scheduled for?
Where can I access Guardant Health's (GH) Q3 2024 earnings webcast?
Will Guardant Health's (GH) Q3 2024 earnings call be available for replay?
